本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.6449
-0.0084-1.29%
盤後0.5802-0.0647-10.03%19:56 EDT
成交量:26.58萬
成交額:17.52萬
市值:392.16萬
市盈率:-4.75
高:0.6799
開:0.6550
低:0.6200
收:0.6533
52周最高:2.79
52周最低:0.5700
股本:608.09萬
流通股本:501.95萬
量比:0.73
換手率:5.29%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
淨資產收益率:-1708.61%
總資產收益率:-22.79%
市淨率:0.92
市盈率(LYR):-4.75

資料載入中...

2019/10/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

SEC問詢函

[Cover]Correspondence
2019/07/24

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]